Bone Healing
-
DTIF-funded project, OsStic® technology awarded #BreakthroughDevice designation by the FDA.
Shannon, Ireland, February 12th 2024: Irish medical device company Biomimetic Innovations Ltd, an affiliate of PBC Biomed, announced ‘Breakthrough Device’ designation from the Food and Drug Administration FDA in January, for the development of a groundbreaking new bio-adhesive bone void filler technology called OsStic®. PBC Biomed leads a consortium for this development project, which is…
-
FDA grants global Medical Device company Biomimetic Innovations ‘Breakthrough Device’ designation for OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler.Â
Shannon, Ireland, 19th January, 2024: Biomimetic Innovations Ltd today announced that OsStic® has been granted ‘Breakthrough Device’ designation by the FDA. The proposed indication statement for this novel new technology is; ” OsStic®Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects…
-
Prof. Luke O’Neill showcasing our partner ZOAN Biomed
Zoan G03, a product created by our partner Zoan Biomed was showcased yesterday evening on new RTÉ show ‘Future Island’. ZoanG03 is a bioactive bone healing device. The corals’ Natural Assembly Process ensures every surface, every pore and every mineral contribute to building a living scaffold. Superior bioactivity stimulates speedy and complete acceptance by…
Search News Items
Categories
- Awards (3)
- Biomaterials (3)
- Bone Adhesive (4)
- Bone Disease Solution (1)
- Bone Healing (3)
- Certification (1)
- Collaboration (8)
- Conferences (5)
- Contract Manufacturing (2)
- Events (27)
- Government Funding (1)
- Lectures (1)
- Medical Devices (3)
- Medical Implants (2)
- Memphis Office (3)
- New Hire (4)
- On TV/Radio (2)
- Press Release (8)
- Publications (5)
- Regenerative Medicine (1)
- Research (5)
- Uncategorized (4)
- Upcoming Events (8)